Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1680062/000114036121016476/brhc10023839_10q.htm
May 2023
April 2023
April 2023
February 2023
February 2023
January 2023
January 2023
January 2023
December 2022
November 2022
Three Months Ended March 31,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||||||
(dollars in thousands, except per share data)
|
||||||||||||||||
Revenue
|
$
|
43,732
|
$
|
24,348
|
$
|
43,732
|
$
|
24,348
|
||||||||
Gross margin
|
41.3
|
%
|
42.0
|
%
|
41.4
|
%
|
42.2
|
%
|
||||||||
Income from operations
|
$
|
3,450
|
$
|
1,218
|
$
|
4,660
|
$
|
1,907
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
5,470
|
$
|
1,705
|
$
|
7,727
|
$
|
2,394
|
||||||||
Basic EPS
|
$
|
0.29
|
$
|
0.09
|
$
|
0.41
|
$
|
0.13
|
||||||||
Diluted EPS
|
$
|
0.25
|
$
|
0.08
|
$
|
0.35
|
$
|
0.11
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to
Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted EPS, also exclude unrealized gain on trading
securities.
|
• |
Shipments. Total shipments in the first quarter of 2021 were $74 million, versus $12
million in the first quarter of 2020 and $67 million in the fourth quarter of 2020. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in
future quarters.
|
• |
Scaling Production Capacity. During the first quarter of 2021, ACM Shanghai leased an
additional building immediately adjacent to its factory in the Chuansha area of Shanghai’s Pudong district. The second building increases available floor space for production by 100,000 square feet, bringing the total available floor
space in Chuansha to 200,000 square feet.
|
• |
Broadened Ultra Fn Furnace Portfolio. During the first quarter of 2021, the Company broadened its Ultra Fn furnace dry processing tool portfolio with additional semiconductor manufacturing processes, including un-doped poly
and doped poly low-pressure chemical vapor deposition (LPCVD). The new capabilities build on the configurable system’s previously announced oxide, silicon nitride (SiN) LPCVD, and alloy annealing process capabilities. ACM has delivered
multiple tools supporting these new applications and expects to deliver additional units in the coming quarters.
|
• |
Update on Engagement with Major First Tier Customers. With resources added to its sales
team, ACM is building a sales pipeline via ongoing engagement and technology discussions with U.S. and Taiwan-based prospects. The Company believes it can secure initial orders from one or more new major first tier customers in 2021.
|
• |
Update on ACM Shanghai IPO Activities. ACM Shanghai's application for an initial public
offering of its shares on the STAR Market was approved by the Listing Committee of the Shanghai Stock Exchange Commission (the “SSEC”) on September 30, 2020. Subsequently a short-seller report issued on October 8, 2020, followed by a
class-action lawsuit on December 21, 2020 that cited the short-seller report, resulted in additional inquiries by the SSEC. In response to those inquiries, ACM completed and submitted to the SSEC a second Verification Report in late
March 2021. Completion of the IPO is now dependent upon, among other factors, a successful review by the SSEC and registration by the China Securities Regulatory Commission.
|
• |
Revenue was $43.7 million, up 79.6%, reflecting an increase in revenue from single wafer
wet cleaning tools, advanced packaging and other back-end processing equipment.
|
• |
Gross margin was 41.3%, compared to 42.0% in the first quarter of 2020. Gross margin
was within the range of 40% to 45% set forth in the Company’s long-term business model. The Company expects gross margin to vary from period to period due to a variety of factors, such as sales volume and product mix.
|
• |
Operating expenses were $14.6 million, an increase of 62.0%. Non-GAAP operating
expenses, which exclude the effects of stock-based compensation, were $13.5 million, up 60.8%. Non‑GAAP operating expenses as a percent of revenue decreased to 30.8%, compared to 34.4% in the first quarter of 2020.
|
• |
Operating income of $3.5 million reflected an increase of 183% due to the increased
revenue and operating leverage. Non-GAAP operating income of $4.7 million reflected an increase of 144%.
|
• |
Unrealized loss on trading securities was $1.0 million in the first quarter of 2021. The
loss reflects the change in market value of ACM Shanghai’s indirect investment in STAR Market IPO shares of Semiconductor Manufacturing International
Corporation (“SMIC”), which began trading in mid-July 2020. The value was marked-to-market at quarter-end and is excluded from non-GAAP results.
|
• |
Net income attributable to ACM Research, Inc. was $5.5 million, compared to $1.7 million
in the first quarter of 2020. Non-GAAP net income attributable to ACM Research, Inc. in the first quarter of 2021, excluding the effect of stock-based compensation and unrealized loss on trading securities, was $7.7 million as compared
to $2.4 million in the first quarter of 2020. Tax-related items (compared to a normalized tax rate), and the effects of foreign-exchange fluctuations on operating results provided net benefits of $3.8 million and $0.6 million in the
first quarters of 2021 and 2020, respectively.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.25, compared to
$0.08 in the first quarter of 2020. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.35 in the first quarter of 2021, compared to $0.11 in the
first quarter of 2020. Tax items and effects of foreign-exchange fluctuations on operating results provided net benefits per share of $0.17 and $0.03 in the first quarters of 2021 and 2020, respectively.
|
• |
Cash and equivalents at quarter-end were $78.8 million, versus $71.8 million at the end
of the fourth quarter of 2020 and $52.3 million at the end of the first quarter of 2020. The quarter-on-quarter increase was primarily due to positive cash flow from operations during the quarter.
|
Phone Number
|
Toll-Free Number
|
|
United States
|
+1 (661) 567-1217
|
+1 (833) 562-0137
|
Hong Kong
|
+852 5819 4851
|
+852 8009 66253
|
Mainland China
|
+86 8008700169
|
|
+86 4006828609
|
In the United States:
|
The Blueshirt Group
|
Ralph Fong
|
|
+1 (415) 489-2195
|
|
ralph@blueshirtgroup.com
|
|
In China:
|
The Blueshirt Group Asia
|
Gary Dvorchak, CFA
|
|
+86 (138) 1079-1480
|
|
gary@blueshirtgroup.com
|
March 31, 2021
|
December 31, 2020
|
|||||||
(Unaudited)
|
||||||||
(In thousands, except share and per share data)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
78,796
|
$
|
71,766
|
||||
Trading securities
|
27,003
|
28,239
|
||||||
Accounts receivable, less allowance for doubtful accounts of $0 as of March 31, 2021 and December 31,
2020
|
60,394
|
56,441
|
||||||
Other receivables
|
11,216
|
9,679
|
||||||
Inventories
|
103,226
|
88,639
|
||||||
Prepaid expenses
|
5,917
|
5,892
|
||||||
Total current assets
|
286,552
|
260,656
|
||||||
Property, plant and equipment, net
|
8,772
|
8,192
|
||||||
Land use right, net
|
9,529
|
9,646
|
||||||
Operating lease right-of-use assets, net
|
5,349
|
4,297
|
||||||
Intangible assets, net
|
602
|
554
|
||||||
Deferred tax assets
|
13,908
|
11,076
|
||||||
Long-term investments
|
6,632
|
6,340
|
||||||
Other long-term assets
|
40,475
|
40,496
|
||||||
Total assets
|
371,819
|
341,257
|
||||||
Liabilities and Stockholders’ Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
23,490
|
26,147
|
||||||
Current portion of long-term borrowings
|
1,598
|
1,591
|
||||||
Accounts payable
|
44,721
|
35,603
|
||||||
Advances from customers
|
32,668
|
17,888
|
||||||
Deferred revenue
|
1,315
|
1,343
|
||||||
Income taxes payable
|
105
|
31
|
||||||
FIN-48 payable
|
82
|
83
|
||||||
Other payables and accrued expenses
|
21,885
|
18,805
|
||||||
Current portion of operating lease liability
|
2,171
|
1,417
|
||||||
Total current liabilities
|
128,035
|
102,908
|
||||||
Long-term borrowings
|
17,444
|
17,979
|
||||||
Long-term operating lease liability
|
3,178
|
2,880
|
||||||
Deferred tax liability
|
1,276
|
1,286
|
||||||
Other long-term liabilities
|
6,639
|
8,034
|
||||||
Total liabilities
|
156,572
|
133,087
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity:
|
||||||||
Common stock – Class A, par value $0.0001: 50,000,000 shares authorized as of March 31, 2021 and December 31, 2020;
17,239,967 shares issued and outstanding as of March 31, 2021 and 16,896,693 shares issued and outstanding as of December 31, 2020
|
2
|
2
|
||||||
Common stock–Class B, par value $0.0001: 2,409,738 shares authorized as of March 31, 2021 and December 31, 2020; 1,769,272
shares issued and outstanding as of March 31, 2021 and 1,802,606 shares issued and outstanding as of December 31, 2020
|
-
|
-
|
||||||
Additional paid in capital
|
104,591
|
102,004
|
||||||
Accumulated surplus
|
39,757
|
34,287
|
||||||
Accumulated other comprehensive income
|
3,961
|
4,857
|
||||||
Total ACM Research, Inc. stockholders’ equity
|
148,311
|
141,150
|
||||||
Non-controlling interests
|
66,936
|
67,020
|
||||||
Total stockholders’ equity
|
215,247
|
208,170
|
||||||
Total liabilities and stockholders’ equity
|
$
|
371,819
|
$
|
341,257
|
Three Months Ended March 31,
|
||||||||
2021
|
2020
|
|||||||
(Unaudited)
|
||||||||
( In thousands, except share and per share data)
|
||||||||
Revenue
|
$
|
43,732
|
$
|
24,348
|
||||
Cost of revenue
|
25,687
|
14,120
|
||||||
Gross profit
|
18,045
|
10,228
|
||||||
Operating expenses:
|
||||||||
Sales and marketing
|
5,308
|
3,005
|
||||||
Research and development
|
5,504
|
3,677
|
||||||
General and administrative
|
3,783
|
2,328
|
||||||
Total operating expenses, net
|
14,595
|
9,010
|
||||||
Income from operations
|
3,450
|
1,218
|
||||||
Interest income
|
49
|
335
|
||||||
Interest expense
|
(189
|
)
|
(111
|
)
|
||||
Unrealized loss on trading securities
|
(1,047
|
)
|
-
|
|||||
Other income, net
|
469
|
677
|
||||||
Equity income in net income of affiliates
|
320
|
148
|
||||||
Income before income taxes
|
3,052
|
2,267
|
||||||
Income tax benefit (expense)
|
2,770
|
(304
|
)
|
|||||
Net income
|
5,822
|
1,963
|
||||||
Less: Net income attributable to non-controlling interests and redeemable non-controlling interests
|
352
|
258
|
||||||
Net income attributable to ACM Research, Inc.
|
$
|
5,470
|
$
|
1,705
|
||||
Comprehensive income:
|
||||||||
Net income
|
5,822
|
1,963
|
||||||
Foreign currency translation adjustment
|
(1,332
|
)
|
(1,900
|
)
|
||||
Comprehensive Income
|
4,490
|
63
|
||||||
Less: Comprehensive income attributable to non-controlling interests and redeemable non-controlling interests
|
(83
|
)
|
(694
|
)
|
||||
Comprehensive income attributable to ACM Research, Inc.
|
$
|
4,573
|
$
|
757
|
||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||
Basic
|
$
|
0.29
|
$
|
0.09
|
||||
Diluted
|
$
|
0.25
|
$
|
0.08
|
||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||
Basic
|
18,786,870
|
18,120,363
|
||||||
Diluted
|
21,868,280
|
21,066,636
|
Three Months Ended March 31,
|
||||||||
Total Revenue By Product Category
|
2021
|
2020
|
||||||
Single Wafer Cleaning Tools (SAPS, TEBO, Tahoe) and Semi-Critical Cleaning Equipment
|
$
|
32,413
|
$
|
22,784
|
||||
ECP (front-end and packaging), Furnace and Other Technologies
|
5,550
|
-
|
||||||
Advanced Packaging (excluding ECP), and Services & Spare Parts
|
5,769
|
1,564
|
||||||
$
|
43,732
|
$
|
24,348
|
Three Months Ended March 31,
|
||||||||
Total Revenue By Equipment Type (Front-end / Back-end)
|
2021
|
2020
|
||||||
Wet Cleaning and Other Front-end Processing Tools
|
$
|
31,900
|
$
|
22,784
|
||||
Advanced Packaging, Other Back-end Processing Tools, and Services & Spare Parts
|
11,832
|
1,564
|
||||||
$
|
43,732
|
$
|
24,348
|
Three Months Ended March 31,
|
||||||||
Total Revenue By Region
|
2021
|
2020
|
||||||
Mainland China
|
$
|
43,696
|
$
|
24,289
|
||||
Other Regions
|
36
|
59
|
||||||
$
|
43,732
|
$
|
24,348
|
Three Months Ended March 31,
|
||||||||||||||||||||||||||||
2021
|
2020
|
|||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
Actual
|
SBC
|
Adjusted
|
||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||
Revenue
|
$
|
43,732
|
$
|
-
|
$
|
-
|
$
|
43,732
|
$
|
24,348
|
$
|
-
|
$
|
24,348
|
||||||||||||||
Cost of revenue
|
(25,687
|
)
|
(71
|
)
|
-
|
(25,616
|
)
|
(14,120
|
)
|
(45
|
)
|
(14,075
|
)
|
|||||||||||||||
Gross profit
|
18,045
|
(71
|
)
|
-
|
18,116
|
10,228
|
(45
|
)
|
10,273
|
|||||||||||||||||||
Gross margin %
|
41.3
|
%
|
0.2
|
%
|
41.4
|
%
|
42.0
|
%
|
0.2
|
%
|
42.2
|
%
|
||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||
Sales and marketing
|
(5,308
|
)
|
(505
|
)
|
-
|
(4,803
|
)
|
(3,005
|
)
|
(94
|
)
|
(2,911
|
)
|
|||||||||||||||
Research and development
|
(5,504
|
)
|
(229
|
)
|
-
|
(5,275
|
)
|
(3,677
|
)
|
(187
|
)
|
(3,490
|
)
|
|||||||||||||||
General and administrative
|
(3,783
|
)
|
(405
|
)
|
-
|
(3,378
|
)
|
(2,328
|
)
|
(363
|
)
|
(1,965
|
)
|
|||||||||||||||
Income from operations
|
$
|
3,450
|
$
|
(1,210
|
)
|
$
|
-
|
$
|
4,660
|
$
|
1,218
|
$
|
(689
|
)
|
$
|
1,907
|
||||||||||||
Operating margin %
|
7.9
|
%
|
2.8
|
%
|
10.7
|
%
|
5.0
|
%
|
2.8
|
%
|
7.8
|
%
|
||||||||||||||||
Unrealized loss on trading securities
|
(1,047
|
)
|
-
|
(1,047
|
)
|
-
|
-
|
-
|
-
|
|||||||||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
5,470
|
$
|
(1,210
|
)
|
$
|
(1,047
|
)
|
$
|
7,727
|
$
|
1,705
|
$
|
(689
|
)
|
$
|
2,394
|
|||||||||||
Basic EPS
|
$
|
0.29
|
$
|
0.41
|
$
|
0.09
|
$
|
0.13
|
||||||||||||||||||||
Diluted EPS
|
$
|
0.25
|
$
|
0.35
|
$
|
0.08
|
$
|
0.11
|
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1680062/000114036121016476/brhc10023839_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acm Research, Inc..
Acm Research, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Rating
Learn More![]()
We have presented shipments, adjusted EBITDA, free cash flow and adjusted operating income (loss) because they are key measures used by our management and board of directors to understand and evaluate our operating performance, to establish budgets and to develop operational goals for managing our business.
We intend to retain all available funds and any future earnings to support the operation of and to finance the growth and development of our business and do not anticipate paying any cash dividends in the foreseeable future.
Shipments, adjusted EBITDA, free cash flow and adjusted operating income (loss) are not prepared in accordance with GAAP, and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP.
31 Table of Contents Projects: Our strategy includes a number of plans to support the growth of our core business, including the STAR Listing and STAR IPO with respect to shares of ACM Shanghai described above as well as ACM Shanghai's recent acquisition of a land use right in the Lingang area of Shanghai where we began construction of a new research and development center and factory in July 2020.
We expect that, for the foreseeable future, general and administrative expenses will increase in absolute dollars, as we incur additional costs associated with growing our business and operating as a public company in the United States and the PRC.
Our cash flow from operating...Read more
Research and development expense consists...Read more
In particular, we believe that...Read more
41 Table of Contents Covenants...Read more
Other income (expense), declined by...Read more
Free Cash Flow The following...Read more
Research and development expense increased...Read more
Critical Accounting Policies and Estimates...Read more
Our future working capital needs...Read more
Consistent with our methodology for...Read more
We have begun to add...Read more
? We define "adjusted EBITDA"...Read more
Income Tax Benefit (Expense) The...Read more
The increase was due to...Read more
The net proceeds of the...Read more
ACM Shanghai currently proposes to...Read more
We expect gross margin to...Read more
32 Table of Contents How...Read more
Accordingly, we believe that these...Read more
We have shown SAPS technology...Read more
TEBO technology has been developed...Read more
To the extent our cash...Read more
Although stock-based compensation is an...Read more
ACM Shanghai was certified as...Read more
36 Table of Contents Comparison...Read more
Sales and marketing expense consists...Read more
Research and development expense relates...Read more
Shipments Shipments consist of two...Read more
The following tables reflect the...Read more
? We define "free cash...Read more
Fluctuations vary depending on cash...Read more
Our effective tax rate differs...Read more
? Government subsidies related to...Read more
The following summary reflects our...Read more
Other Income and Expenses 39...Read more
Upon the termination of such...Read more
During the second quarter of...Read more
Other income, net primarily reflects...Read more
For the three months ended...Read more
Cost of Revenue and Gross...Read more
The increase was due in...Read more
Since that time, we have...Read more
The extent to which COVID-19...Read more
33 Table of Contents The...Read more
We believe our existing cash...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Acm Research, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ACMR
CIK: 1680062
Form Type: 10-Q Quarterly Report
Accession Number: 0001140361-21-016476
Submitted to the SEC: Fri May 07 2021 5:04:23 PM EST
Accepted by the SEC: Fri May 07 2021
Period: Wednesday, March 31, 2021
Industry: Special Industry Machinery